1. Introduction {#sec1}
===============

Osteoarthritis (OA), originating from the Greek words "bone", "joint", and "inflammation", is one of the most common causes of pain and disability in middle-aged and older people.[@bib1] OA is currently considered an inflammatory disorder of movable joints that is involved in several pathological features such as deterioration and abrasion of articular cartilage and formation of new bone at the articular surface and subchondral bone, resulting in limitation of joint movement.[@bib2], [@bib3], [@bib4] The incidence of symptomatic OA is likely to increase because of the aging population and obesity epidemic.[@bib5] In the United States, the prevalence of OA of the knee (膝關節炎 xī guān jié yán) is 10% in men and 13% in women in millions among adults 60 years of age or older in 2010.[@bib5] Radiographic evidence of OA generally appears in those over 65 years of age, approximately 80% of whom are over 75 years of age.[@bib6] OA is essentially an inflammatory disease, causing signs and symptoms of inflammation such as stiffness and joint effusion.[@bib4] OA causes articular cartilage loss, capsular stretching, muscle weakness, bony remodeling, synovitis, and ligament laxity, ultimately leading to malalignment of the knee joint. The abnormal structure resulting from OA causes abnormal focal stress in the knee joint and induces a vicious cycle of joint damage. The major complaint of patients with OA of the knee is pain derived from tearing of the patella-femoral joint, inflammation of soft tissue, and collection of synovial fluid.[@bib3], [@bib7] Treatment of OA includes intraarticular corticosteroid injection, oral acetaminophen, capsaicin cane, and nonsteroidal antiinflammatory drugs (NSAIDs).[@bib8]

According to the basic theory of traditional Chinese medicine (TCM; 中醫 zhōng yī), OA is an "impediment disease (痹病 bì bìng)", which refers to a group of diseases resulting from "invasion of wind, cold, and dampness (風寒濕侵襲 fēng hán shī qīn xí)".[@bib9] Mavrommtis et al (2012) reported that acupuncture (針灸 zhēn jiǔ) with etoricoxib reduced pain more than did sham acupuncture with etoricoxib or etoricoxib alone in patients with knee OA.[@bib10] Duhuo Jisheng Tang treatment for 4 weeks can reduce pain and stiffness and improve physical function in knee OA patients.[@bib11] Moxibustion (艾灸 ài jiǔ) is a traditional therapy to treat diseases through thermal stimulation by burning herb when the knee pain was due to "the invasion of the cold (風邪侵襲 fēng xié qīn xí)".[@bib12] Herbal patch (藥布 yào bù) is made through the powder of the herbs, vegetable oil and excipient, like *Componere Hydrargyrum* (Shenyao), then cooling and coating with cloth or paper. Herbal patch is placed on the injured area or acupoint (穴位 xué wèi) for reducing "swelling and pain (腫痛 zhǒng tòng)".[@bib13] Qigong (氣功 qì gōng) is an energy exercise and therapy that assume the existence of a "Qi (氣 qì)" circulating throughout the body and in the surrounding environment.[@bib14] Massage therapy (推拿 tuī ná) is that the doctor uses their hands to manipulate the patient\'s body to relax and "dredge the meridians (疏通經絡 shū tōng jīng luò)" and promote "Qi flowing and blood circulating (氣血循環 qì xuè xún huán)".[@bib15] Therefore, the aim of the present study was to determine whether the use of TCM influences symptoms or functional outcomes in patients with OA of the knee through a systematic review of randomized control trials (RCTs) from the PubMed and MEDLINE databases.

2. Materials and methods {#sec2}
========================

2.1. Data source and review process {#sec2.1}
-----------------------------------

The PubMed database was used to search for relevant studies conducted between 1965 and August 2013. The PubMed database comprises more than 23 million citations of biomedical literature from MEDLINE, life science journals, and online books. The articles used in our analysis were published in English, and the full text of these studies is available through PubMed Central and publisher web sites. The keywords in our study were osteoarthritis, traditional Chinese medicine (TCM; 中醫 zhōng yī), acupuncture (針灸 zhēn jiǔ), herb, e herbal patches (藥布 yào bù), moxibustion (艾灸 ài jiǔ), Massage therapy (推拿 tuī ná) and qigong (氣功 qì gōng). TCM indicates the use of acupuncture, herbs, herbal patches, moxibustion, massage therapy, or integration for treatment. The major keyword "osteoarthritis" was combined with the other keywords separately. For example, "((osteoarthritis) AND acupuncture) AND English \[Language\]" or (osteoarthritis) AND Traditional Chinese Medicine AND English \[Language\], to search relevant RCTs for all TCM treatments for OA. Articles satisfying the search criteria were entered into a review process, and the full texts collected according to the criteria were further reviewed.

2.2. Types of studies {#sec2.2}
---------------------

Only RCTs with participants appropriately allocated into treatment and control groups were included in our study. RCTs that 1) were placebo-based or comparative; 2) were open label, single-blinded or double-blinded; 3) evaluated the efficacy of TCM in OA of the knee; or 4) evaluated TCM only or a combination of preparations were included.

2.3. Types of participants {#sec2.3}
--------------------------

The inclusion criteria referred Zhang and Jordan (2010)[@bib5] for participants were (1) an age \>50 years and (2) symptoms and signs of OA of the knee. Patients with at least three of the following characteristics were considered to have typical symptoms and signs of OA: (A) morning stiffness lasting fewer than 30 min; (B) a crackling or grating sensation; (C) bony tenderness of the knee; (D) bony enlargement of the knee; and (E) no detectable warmth of the joint to the touch. The exclusion criteria were (1) OA secondary to other etiologies such as trauma, infection, and rheumatoid arthritis; (2) OA located at multiple sites, and inability of the treatment to target specific joints and (3) if those multiple sites included OA of knee.

2.4. Types of interventions {#sec2.4}
---------------------------

The types of interventions analyzed in our review were acupuncture or electroacupuncture (EA; 電針 diàn zhēn), herbs or formulas, herbal patches, moxibustion, qigong and massage therapy, according to the theory of TCM. Studies designed to treat OA by integrating TCM and modern medicine was also included. Studies involving laser acupuncture or acupuncture with local drug injections and nonclinical studies, such as animal and cell line studies, were excluded.

2.5. Types of outcome measurement {#sec2.5}
---------------------------------

The studies analyzed in this review were required to include an assessment before and after intervention and a follow-up period. All studies applied tools for assessing the effectiveness of treatment, namely (1) tools for measuring pain intensity such as the Visual Analogue Scale (VAS) and Numeric Rating Scale (NRS) and (2) tools for measuring functional status or disability including the Western Ontario and McMaster Universities Arthritis Index (WOMAC), Short Form 36 (SF-36) health survey, and other reliable and valid methods. The timing of assessment was recorded, and the evaluations were blinded.

2.6. Risk-of-bias assessment and quality {#sec2.6}
----------------------------------------

The checklists of the Cochrane back review group were used as a methodological template to assess the risk of bias of individual RCTs. The methodological quality of trials was classified as "low", "moderate", and "high" by using a trial method adapted from previous guidelines ([Table 1](#tbl1){ref-type="table"}),[@bib16], [@bib17] and studies rated equal or more than 6 of 12 were considered to have a low risk of bias.

2.7. Quality of evidence {#sec2.7}
------------------------

The overall quality of evidence was evaluated according to the Grades of Recommendation, Assessment, Development, and Evaluation (GRADE) criteria, as in previous research[@bib18] ([Table 2](#tbl2){ref-type="table"}). In brief, studies that were observational, limited, inconsistent, indirect, or imprecise or exhibited publication bias were considered to yield "low-quality" evidence. By contrast, studies that involved randomized trials and large effect sizes and showed evidence of a dose-response gradient were considered to provide "high-quality" evidence. Furthermore, when researchers attempted to eliminate all potential confounding factors, the results were considered high-quality evidence.

2.8. Data extraction {#sec2.8}
--------------------

Data were analyzed and summarized using a standard form that comprised the following items: author/year/country, study design, participants, intervention, outcome measures, and results ([Table 3](#tbl3){ref-type="table"}, [Table 4](#tbl4){ref-type="table"}, [Table 5](#tbl5){ref-type="table"}, [Table 6](#tbl6){ref-type="table"}).

3. Results {#sec3}
==========

3.1. Study selection and exclusion {#sec3.1}
----------------------------------

Studies were identified through PubMed according to the inclusion criteria. The protocol of data analysis and reasons for exclusion are summarized in [Fig. 1](#fig1){ref-type="fig"}. In summary, 104 studies were identified, and 21 studies were removed because of duplication. Eighty-three studies were screened again by reviewing the abstracts according to the inclusion and exclusion criteria. Studies that were impossible to include or exclude were retained until a full-text assessment could be conducted. Forty-two studies were included after assessing the descriptions of the full-text articles. Finally, 18 studies were included in our analysis ([Table 3](#tbl3){ref-type="table"}), and 24 studies were excluded because five studies did not include results, three related to communication skill, six lacked definite analyses, one focus in economics only, one was a letter, six were not relevant to the study objective, one related to a patient\'s expectations, and one lacked a discussion of a RCT. Twelve studies involved acupuncture (針灸 zhēn jiǔ) application[@bib10], [@bib21], [@bib22], [@bib23], [@bib24], [@bib25], [@bib26], [@bib27], [@bib28], [@bib29], [@bib30], [@bib31] ([Table 3](#tbl3){ref-type="table"}), one involved herbal patch (藥布 yào bù) application[@bib13] ([Table 4](#tbl4){ref-type="table"}), two involved herbal medicine application[@bib32], [@bib33]([Table 5](#tbl5){ref-type="table"}), and three involved qigong (氣功 qì gōng) application for OA treatment[@bib14], [@bib34], [@bib35] ([Table 6](#tbl6){ref-type="table"}). No studies involvingmassage therapy (推拿 tuī ná), moxibustion (艾灸 ài jiǔ), or integrated therapy for OA were included in our analysis. Meta-analysis could not be conducted because of the heterogeneous study designs and treatment modalities of the included trials.

3.2. Risk of bias in the included studies {#sec3.2}
-----------------------------------------

The risk of bias in the studies that we analyzed is shown in [Table 1](#tbl1){ref-type="table"}. Although 18 studies were described as randomized, nine lacked adequate randomization and concealed allocation, two lacked the inclusion of similar groups at the baseline, three lacked adequate or clear blinding, two lacked an acceptable dropout rate, five lacked an intention-to-treat analysis, three lacked adequate co-intervention, one lacked adequate compliance, one lacked an adequate timing outcome assessment, and one lacked adequate selective outcome reports.

Ten studies were considered to have high methodological quality (≧10/12), six had moderate methodological quality (6--9/12), and two had low methodological quality (\<6/12). Seven studies with high methodological quality and five studies with moderate methodological quality involved acupuncture treatment. One study with moderate methodological quality and one study with low methodological quality involved herbal treatment. One study with high methodological quality involved herbal patch treatment. Two studies with high methodological quality and one study with low methodological quality involved qigong treatment ([Table 7](#tbl7){ref-type="table"}, [Table 8](#tbl8){ref-type="table"}, [Table 9](#tbl9){ref-type="table"}, [Table 10](#tbl10){ref-type="table"}).

3.3. Effects of intervention {#sec3.3}
----------------------------

The effects of TCM intervention on knee OA (膝關節炎 xī guān jié yán) are summarized according to modality, namely acupuncture ([Table 3](#tbl3){ref-type="table"}), herbal patches ([Table 4](#tbl4){ref-type="table"}), herbs ([Table 5](#tbl5){ref-type="table"}), and qigong ([Table 6](#tbl6){ref-type="table"}).

### 3.3.1. Acupuncture treatment for OA {#sec3.3.1}

#### 3.3.1.1. Acupuncture in pain control for OA {#sec3.3.1.1}

The eleven of 12[@bib10], [@bib24], [@bib26], [@bib30], [@bib31] studies have reported that acupuncture can reduce pain in patients with OA of the knee. Among these studies, nine (five high[@bib10], [@bib21], [@bib24], [@bib25], [@bib26] and four moderate quality[@bib23], [@bib28], [@bib29], [@bib30]) showed statistically significant pain reductions, and two (one high[@bib22] and one moderate quality[@bib31]) showed non-significant pain reductions. One[@bib27] of 12 studies did not report a reduction in pain. Eight[@bib10], [@bib21], [@bib23], [@bib24], [@bib26], [@bib28], [@bib29], [@bib30] of nine studies that showed statistically significant reductions in pain used the VAS or NRS for pain assessment and one[@bib25] study used the WOMAC pain scale.

Eight studies have demonstrated that acupuncture can significantly improve physical function in patients with knee OA.[@bib10], [@bib22], [@bib23], [@bib24], [@bib25], [@bib26], [@bib29], [@bib30] Among these studies, five had high quality,[@bib10], [@bib22], [@bib24], [@bib25], [@bib26] and three had moderate quality.[@bib23], [@bib29], [@bib30] Seven (five high[@bib10], [@bib22], [@bib24], [@bib25], [@bib26] and two moderate[@bib23], [@bib29] quality) of eight studies used the WOMAC for pain assessments. Only one[@bib30] of eight studies used gait analysis as its assessment for physical function.

### 3.3.2. Herbal patch {#sec3.3.2}

Only one high-quality study involving herbal patch treatment for OA was analyzed in our review.[@bib13] This study demonstrated that herbal patch treatment reduced pain and improved physical function, but these positive effects were not statistically significant. This study used the VAS for pain measurement and the WOMAC for functional assessment.

### 3.3.3. Herbs {#sec3.3.3}

Only one moderate-quality study involving the treatment of OA with herbs showed that herbs significantly reduced pain according to the VAS.[@bib23], [@bib32] The other study involving herbal treatment of OA had low quality and did not show a significant pain reduction.[@bib21], [@bib33]

Regarding of physical function, the results were the same as those mentioned previously. Only one moderate-quality study on herbal therapy showed a significant increase in physical function according to the WOMAC.[@bib33]

### 3.3.4. Qigong {#sec3.3.4}

Two studies showed a significant reduction in pain resulting from qigong treatment. One of these two studies provided high-quality evidence and used the McGill Pain Questionnaire as a pain scale.[@bib14] The other study provided low-quality evidence and used the WOMAC for pain measurement.[@bib34] One study[@bib35] included in this paper did not have an assessment of pain.

For improved physical function resulting from qigong treatment, one high-quality study showed an improvement in SF-36 and 6-m walking test significantly, but this improvement of WOMAC functional scale was not significant.[@bib35] Another high-quality study[@bib14] showed no improvement in physical function, and a low-quality study showed statistically significant improvements in physical function according to the WOMAC functional scale, 6-m walking test and ISKE (Isokinetic Strength of the Knee Extensors).[@bib34]

3.4. Quality of evidence {#sec3.4}
------------------------

Regarding the quality of evidence, no studies provided high-quality according to the GRADE criteria. Moderate-quality evidence supported reduced pain after a therapeutic course of acupuncture. Low-quality evidence supported improved function after acupuncture treatment or qigong. No evidence supported improved function after treatment with herbs or qigong. Because only one study regarding herbal patch treatment was analyzed, its quality of evidence could not be analyzed using the GRADE criteria ([Table 11](#tbl11){ref-type="table"}, [Table 12](#tbl12){ref-type="table"}, [Table 13](#tbl13){ref-type="table"}).

4. Discussion {#sec4}
=============

In this review, eighteen studies were included to determine the efficacy of TCM (中醫 zhōng yī) in patients with OA of the knee (膝關節炎 xī guān jié yán). We found that the studies involving acupuncture (針灸 zhēn jiǔ) and herbal patch (藥布 yào bù) treatments had lower risks of bias than those involving other TCM treatments. In addition, we found that studies involving acupuncture and herbal patch treatments had high methodological evidence regarding reduction of pain and improvement of physical function in patients with knee OA. By contrast, the risk of bias and quality of evidence regarding studies involving the application of herbal medicine for treating knee OA was inadequate because of methodological problems. No RCTs were conducted regarding the use of massage therapy (推拿 tuī ná) or moxibustion (艾灸 ài jiǔ), and RCTs should be developed for these treatments. Evidence regarding the effect of acupuncture on pain scores and the effect of qigong (氣功 qì gōng) on function scores was less conflicting.

Since the 1970s, acupuncture has become a prevalent therapy for pain.[@bib36], [@bib37] In recent years, research has focused more on acupuncture than on other TCM treatments for pain control, and the quality of studies on acupuncture has improved. However, research on TCM therapies other than acupuncture for pain control remains insufficient. The results of our review show fewer RCTs on TCM, but acupuncture for treating knee OA pain could partially explain this phenomenon. In addition, most Chinese herbal medicines (中草藥 zhōng cǎo yào) are pure compounds, and few RCTs have applied herbal medicine and herbal patches to treat knee OA.[@bib34], [@bib38] The decision to use acupuncture, massage therapy, or herbal medicine and patches for OA may correlate with the pathogenesis of OA and the aim of treatment. In general, acupuncture and massage therapy can alter muscle imbalance or fascial tension and reduce inflammation and pain in the early stages of OA,[@bib21], [@bib23], [@bib24], [@bib26] whereas herbal medicines and patches can reduce inflammation locally but cannot alter abnormal alignment and the degenerative process.[@bib13], [@bib32]

4.1. Methodological considerations {#sec4.1}
----------------------------------

Several factors contributed to a low quality of evidence or lack of evidence. Regarding acupuncture, three of 12 studies lacked clear random sequence generation, four lacked clear allocation concealment, two lacked adequate assignment of participants to groups, three lacked an intention-to-treat analysis, and three lacked adequate blinding. Only two studies did not have serious limitations. Although nine studies showed that acupuncture significantly relieved pain, two studies without serious limitations did not show significant pain relief following acupuncture. All patients in the 12 studies were diagnosed with OA, eight studies used the VAS as a pain scale, and four studies used the NRS to evaluate pain severity. Seven studies showed that acupuncture significantly improved physical function. The other studies did not show improved physical function. One study without serious limitations showed significantly improved physical function. The most critical study limitation among the analyzed studies was that most studies did not effectively explain processes for reducing bias.

Both studies on herbal medicine lacked clear random sequence generation and allocation concealment. Although both studies showed pain relief, neither could that show this pain relief was significant. Only one study showed significantly improved function. Currently, data are not sufficient to show a clear benefit of herbal medicine in patients with knee OA compared with controls.

Regarding qigong treatment, one of three studies lacked clear random sequence generation and allocation concealment, and two studies did not use an intention-to-treat analysis. One study did not determine a pain score, but used the WOMAC, which contains a subscale of the pain scale. Two studies showed that qigong treatment significantly reduced pain. Three studies showed improved physical function as a result of qigong treatment, but only one showed significantly improved physical function. According to our results, studies that showed improved physical function in patients treated with qigong had a moderate quality of evidence.

Regarding herbal patch treatment, only one study included random sequence generation and allocation concealment, but these processes were unclear. The bias was introduced. Although this study had a low risk of bias, more studies are required to eliminate the bias and increase the quality of evidence.

Despite 10 of 18 studies having high methodological quality (≧10/12), these studies were collectively flawed regarding random sequence generation, allocation concealment, compliance, and dropout rates. Our review findings were significantly influenced by these shortcomings. The quality of future RCTs must be improved to reduce bias in future reviews.

4.2. Review strengths and limitations {#sec4.2}
-------------------------------------

The literature search and selection procedure used in this review may have introduced bias. The literature search was conducted only in English, and only one database was used. Some RCTs may have been located in other databases or recorded in other languages. According to our selection procedure, the pathology of knee OA was not limited, and some patients developed OA as a result of trauma or infection rather than idiopathy or degeneration. These cases may have caused bias in our review. Patients with different demographics should be examined with caution.

Studies published after August 2013 or unpublished studies may have been omitted from our review. Using references from studies included in our review to identify other studies may have led to an overrepresentation of positive studies.

This review did not involve meta-analysis, and these studies should be divided into several categories according to various designs, for example, comparison between an experimental group and placebo or control groups, or comparison between an experimental group and standard treatment or control groups. If these studies were divided, we could compare them more effectively.

The studies included in our review were conducted between 1965 and 2013, and nearly all RCTs in the PubMed database involving TCM for knee OA were initially selected. After screening, 18 studies were included in our review.

4.3. Implications for health practice {#sec4.3}
-------------------------------------

OA of the knee is extremely prevalent among elderly people and interferes with their daily activities. Many elderly people cannot engage in daily activities including sports, shopping, and travel because of pain or the inability to walk. Furthermore, many elderly people visit hospitals or clinics because of pain and limited ranges of motion, causing a financial burden on the health care system in Taiwan. Current treatment options such NSAIDs, hyaluronic acid injection, and total knee arthroplasty are ineffective in treating OA. Glucosamine sulfate seems to be an alternative solution for treating OA, but evidence regarding its efficacy remains equivocal. TCM is another solution for treating OA.

According to our review, acupuncture seems to be effective for pain relief, and qigong seems effective for improving physical function. Only five papers[@bib10], [@bib21], [@bib24], [@bib25], [@bib26] have statistically significant about reducing pain and attach the high quality of methodological evidence. The usually used acupuncture points were local points including ST36, GB34, SP9, EX-LE5 (Xiyan), ST-35 (Dubi) and distant points are including LI4, SP6, KI3. The T\'ai chi (太極拳 tài jí quán) is a low-impact, low-intensity and easy exercise with low drop-out rate, it can serve more activity for elderly patients with OA knee.[@bib35] Many mechanisms through which acupuncture exerts analgesic effects have been introduced. The major mechanisms that are currently accepted are the endogenous opiate mechanism and descending inhibitory mechanism.[@bib36], [@bib39], [@bib40] In support of this theory, evidence shows that the opioid antagonist naloxone blocks the analgesic effects of acupuncture.[@bib39], [@bib41] Endogenous opioids are mediated by their μ, δ, and κ receptors, and the descending inhibitory pathway is mediated by its monoaminergic neurotransmitters and their receptors.[@bib42] In response to injury of the human body, the peripheral injury information is transmitted to substantia gelatinosa cells by primary afferent fibers, and the signal then ascends to the brain through the spinothalamic tract. Stimulation through EA could produce signals from the marginal cell tract that are transmitted to the brain through the spinothalamic tract.[@bib43], [@bib44] Signals transmitted to the cortex and intrinsic dorsal neurons evoke cholinergic, ENKergic, and GABAergic neurons that can inhibit substantial gelatinosa cells.[@bib19], [@bib36] The signal is then transmitted to the periaqueductal gray and nucleus raphe magnus to inhibit substantia gelatinosa cells by 5-HT. Another path from the cortex is the locus coeruleus. The signal from the locus coeruleus inhibits substantia gelatinosa cells and primary afferent fibers and enhances cholinergic, ENKergic, and GABAergic neurons through norepinephrine.[@bib36] Because these pathways originating from EA can inhibit nociceptive inputs from the periphery to higher areas in the CNS, acupuncture is useful for relieving pain.[@bib36]

Qigong is effective for improving OA knee function and is the only treatment that requires moving patients\' bodies and exercising their knee joints. Two of three qigong studies in our review involved -- T\'ai chi and Baduanjin (八段錦 bā duàn jǐn), and the other study involved external qigong therapy for which patients were not required to move their knees. T\'ai chi and Baduanjin significantly improved function, but external qigong therapy did not significantly improve function. Compared with patients treated with acupuncture, patients treated with physical therapy had lower mean walking times, but this difference was nonsignificant.[@bib27] According to myofascial theory, pain from inflammation and friction of articular surfaces may induce muscle spasms around the joint, and the muscle spasms cause muscle ischemia. The ischemic soft tissue then causes more pain, which causes another muscle spasm.[@bib45], [@bib46] Finally, a taut band and trigger point form, and the range of motion becomes limited. Limited range of motion and muscle spasms cause joint contractures and increase the difficulty of walking in elderly people. Low-impact, low-intensity exercise therapies, such as T\'ai chi and Baduanjin, benefit elderly patients because these patients can stretch the muscles around the knees, such as the calf muscles and hamstrings, and break the pain-spasm-pain cycle.

Herbal medicine and patches are used to eliminate inflammation or improve circulation of the knees.[@bib13], [@bib32] Park et al (2009) used AIF (*Panax notoginseng* (三七 sān qī), *Rehmannia glutinosa Libosch* (地黃 dì huáng), and *Eleutherococcus senticosus* (刺五加 cì wǔ jiā)) to treat OA knee and the VAS score and K-WOMAC decreased significantly. Li et al (2010) used recipe (*Rhizoma Pinelliae* (半夏 bàn xià), *Arisaema cum* Bile (膽南星 dǎn nán xīng), *Rhizoma Chuanxiong* (川芎 chuān xiōng), *Radix Angelicae Sinensi*s (當歸 dāng guī), *Radix Morindae Officinalis* (巴戟天 bā jǐ tiān), *Radix Paeoniae Alba* (白芍 bái sháo), *Rhizoma Atractylodis* (蒼朮 cāng zhú), *Rhizoma seu Radix Notopterygii* (羌活 qiāng huó), *Radix Angelicae Pubescentis* (獨活 dú huó), *Rhizoma Corydalis* (延胡索 yán hú suǒ), *Radix Astragal*i (黃耆 huáng qí) and *Radix Achyranthis Bidentatae* (懷牛膝 huái niú xī)) to heal OA knee and the decreased symptoms and effective rate were better in the treatment group but no statistic difference. Although these papers can improve symptoms, their quality evidence is no evidence and the methodological evidence is low to moderate.[@bib21], [@bib23] The evidence regarding the effects of these therapies remains equivocal, and further study is required to prove their efficacy.

Other TCM therapies, such as massage therapy and manipulation, are oriental therapies, the effects of which can be studied further. We found that there were not many papers to study this area and we think this area needed to develop more rigorous studies. OA is a degenerative disease and always causes mal-alignment of the bone structure. In Taiwan, many elderly people with knee pain receive massage therapy and manipulation therapies to relieve pain and improve function. The mechanism of muscle spasm release involved in massage therapy and manipulation may be the same as that involved in active low-intensity muscle exercise, but massage therapy and manipulation are passive rather than active.

5. Conclusion {#sec5}
=============

This was a systematic review investigating the evidence regarding TCM (中醫 zhōng yī) effectiveness in patients with OA of the knee (膝關節炎 xī guān jié yán). The initial findings of this review suggest that acupuncture (針灸 zhēn jiǔ) is a promising intervention according to the primary outcome measures of pain, and qigong (氣功 qì gōng) with motion is an effective method for treating physical function. However, based upon the GRADE criteria, the evidence for PNE is currently graded as moderate quality. This treatment approach should be investigated further to determine its most effective clinical use.
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###### 

Criteria for judging the quality of individual trials.

  ---------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  High       \>75% of the criteria have been fulfilled \[≧10/12\]. Where they have not been fulfilled the conclusions of the study or review are thought very unlikely to alter.
  Moderate   50--75% of the criteria have been fulfilled \[6--9/12\]. Those criteria that have not been fulfilled or not adequately described are thought unlikely to alter the conclusions.
  Low        Less than 50% of the checklist criteria were fulfilled \[\<6/12\]. The conclusions of the study are thought likely or very likely to alter.
  ---------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

This table is adapted from Liddle et al.[@bib12], [@bib16]

###### 

The evidence grading system applied in this review.

  ------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------
  High          At least 75% of the RCTs with no limitations of study design have consistent findings, direct and precise data and no known or suspected publication bias.
  Moderate      One of the domains is not met.
  Low           Two of the domains are not met.
  Very low      Three of the domains are not met.
  No evidence   No RCTs were identified that addressed this outcome.
  ------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------

This table shows the CBRG recommended quality of evidence grading system that was applied to each outcome measure.[@bib19], [@bib20]

###### 

Osteoarthritis (OA) of the knee intervention with "Acupuncture (針灸 zhēn jiǔ)".

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Basic information of researches       Participants                                                                                                                                                                                                                                  Intervention                                                                                                                                                                                                                                                                                                                                                                                                                                                                Outcome assessment                                                                                                                                                                                                                                                                  Results                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  The risk of bias
  ------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------
  Ng MM et al[@bib21]\                  N = 24 (diagnosed with OA knee)\                                                                                                                                                                                                              EA treatment (N = 8):(1)ST-35 and EX-LE-4,(2)De-Qi (得氣 dé qì)",(3)EA TENS Group (N = 8):the procedures were the same as EA group except surface electrodes were used instead of needle insertionControl group (N = 8):\                                                                                                                                                                                                                                                   •Pain:numerical rating scale of pain•Function:passive range of movement of the OA knee; the Timed Up-and-Go test (TUGT)                                                                                                                                                             •For the EA group, there was a significant reduction of mean NRS of knee pain (229%) after eight sessions of treatment (p = 0.01), and the effect was well maintained (231%) at the 2-week follow-up evaluation (p = 0.01).•A reduction of mean NRS of knee pain (228%) was significant in the TENS group after eight sessions of treatment (p = 0.01) but at the 2-week follow-up evaluation, the effect became less pronounced.•The total passive knee ROM was not significantly different among the three groups across the period of study.•There was a significant improvement (11%) in the TUGT scores in the EA group after eight sessions of treatment.                                                                                                                          10/12 (High)
  2003, Hong Kong, China\               Inclusion criteria:(1)Knee pain during the preceding month(2)morning stiffness less than 30 min,(3)crepitus,(4)bony enlargement,(5)stable condition under arthritis medication                                                                Subjects received general education on osteoarthritic knee care only                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
  (RCT)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
  (Patient-blind)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
  (Assessor-blind)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  Berman BM et al[@bib22]\              N = 570\                                                                                                                                                                                                                                      True acupuncture group (N = 190):(1)acupoints (穴位 xué wèi) (5 local and 4 distal points) by TCM theory,(2)De-Qi",(3)EASham control (N = 191):(1)No needle insertion,(2)the procedure is the same as true acupuncture group,Education group (N = 189):(1)6 two hour group sessions based on the Arthritis Self-Management Program                                                                                                                                          •Pain:WOMAC pain score•Function:WOMAC function score; SF-36; the 6-min walk time; the patient global assessment                                                                                                                                                                     •While WOMAC pain among participants who were receiving true acupuncture decreased more than in the sham group at all of the post baseline assessments (no statistically significant difference).•The true acupuncture group\'s improvement in WOMAC function from baseline was significantly greater than that of the sham control group at weeks 8.•Changes in overall physical component score did not statistically significantly differ between the true versus sham acupuncture groups.                                                                                                                                                                                                                                                                                            11/12 (High)
  2004, USA\                            Inclusion criteria:(1)Age ≧50 years,(2)diagnosis of OA of the knee,(3)K-L^∗^ grade ≧2,(4)moderate or great knee pain during the past month,(5)willingness to be randomly assigned                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      
  (RCT)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
  (Patient-blind)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
  (Assessor-blind)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  Tukmachi E et al[@bib23]\             N = 30\                                                                                                                                                                                                                                       Group A (N = 9):(1)Acupuncture alone,(2)stop NSAIDs and analgesic drugs,(3)"De-Qi"(4)8 acupoints used traditionally with EAGroup B (N = 10):(1)Acupuncture and their existing analgesic and anti-inflammatory medicationGroup C (N = 10):(1)week 1--5: current medications,(2)week6--10: acupuncture plus medications                                                                                                                                                       •Pain:VAS(10-cm)•Function:WOMAC; global assessment                                                                                                                                                                                                                                  •Group C showed no change in pain score during the first five weeks while waiting for acupuncture. After acupuncture there was a large and statistically significant drop in the VAS pain score for all three treated groups.•In groups A and B the significant improvement in pain score was maintained when the patients attended for the final visit.•WOMAC stiffness scores decreased by more than half in groups B and C after the course of acupuncture. The reduction was less dramatic in group A, but still significant and still present one month later.                                                                                                                                                                                                                      7/12 (Moderate)
  2004, UK\                             Inclusion criteria:(1)Age ≧18 years,(2)OA of the knee≧6 months,(3)K-L, grade IV(4)no response to previous treatment(5)no previous acupuncture                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
  (RCT)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  Vas J et al[@bib24]\                  N = 97\                                                                                                                                                                                                                                       Intervention group (N = 48)(1)acupuncture plus diclofenac,(2)Acupoints based on traditional treatment methods,(3)"De-Qi"(4)EAControl group (N = 49):(1)placebo acupuncture plus diclofenac(2)the procedures were the same as true acupuncture(3)no needle penetration.                                                                                                                                                                                                      •Pain:WOMAC pain scaleVAS(100-mm)•Function:WOMAC stiffness and function scale•Others:the dosage of diclofenac accumulated; the profile of quality of life in the chronically ill (PQLC)                                                                                             •The WOMAC index and VAS presented a greater, and significant, reduction in the intervention group than in the control group.•A reduction of 53.9 was observed in the total accumulated number of diclofenac tablets for the intervention group compared with the control group.•The PQLC results indicate that acupuncture treatment produces significant changes in physical capability and psychological functioning.                                                                                                                                                                                                                                                                                                                                                                 10/12 (High)
  2004, Spain\                          Inclusion criteria:(1)Diagnosed by ACR criteria(2)written informed consent(3)Age ≧45 years,(4)pain more than 3 months,(5)Grade 1 of Ahlback classification                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
  (RCT)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
  (Patient-blind)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
  (Assessor-blind)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  Witt C et al[@bib25] 2005, Germany\   N = 300\                                                                                                                                                                                                                                      Acupuncture group (N = 150):(1)semi-standardized (TCM), 6 local and 2 distal acupoints,(2)"De-Qi"Minimal acupuncture group (N = 76):(1)superficial insetion at non-acupuncture point,(2)at least eight out of ten pointsWaiting list (N = 74):(1)No acupuncture for 8 weeks after randomization,(2)recieve 12 sessions of acupuncture from week 9.                                                                                                                          •Pain and function: WOMACPain Disability Index (PDI)SF-36 (German version)•Others:Schmerzempﬁndungs-Skala \[SES\]; Allgemeine; Depressionsskala \[ADS\]; questions about workdays lost                                                                                              •On all WOMAC subscales (pain, stiffness, and physical function), the acupuncture group showed significant improvements compared with the minimal acupuncture and the waiting list groups.•Patients who received acupuncture had significantly better results for almost all secondary outcome measures than did those in the minimal acupuncture and waiting list groups.                                                                                                                                                                                                                                                                                                                                                                                                               10/12 (High)
  (RCT)\                                Inclusion criteria:(1)age 50--75 years(2)diagnosed by ACR criteria,(3)K-L^∗^ grade ≧2(4)average VAS (100 mm) ≧40 in the 7 days before baseline assessment(5)written informed consent                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
  (Patient-blind)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  Scharf HP et al[@bib26]\              N = 1039\                                                                                                                                                                                                                                     Conservative therapy (N = 342):(1)diclofenac, up to 150 mg/d, or rofecoxib, 25 mg/d(2)6 Physiotherapy sessionsTCA + conservative therapy (N = 330):(1)10 acupuncture sessions,(2)2 of 16 defined points were chosen and 4 Ashi points,(3)consercative therapy was the same as above.Sham + conservative therapy (N = 367):(1)minimal-depth needling without stimulation at 10 points at defined distances from TCA points.(2)the other procedures were the same as above.   •Pain:WOMAC pain scale•Function:WOMAC function scale (Success rates were calculated according to a change of at least 36% from baseline WOMAC scores at 13 and 26 weeks after the start of treatment.)•Others:The dichotomized global patient assessment; SF-12 physical subscale   •Statistically significantly increased success rates in the TCA and sham acupuncture groups compared with the conservative therapy group (p \< 0.001 for both comparisons) and no difference between the TCA and sham acupuncture groups (p = 0.48).•Statistically signiﬁcant changes with respect to total WOMAC score. The changes in the TCA and sham acupuncture groups were much more distinct than those measured in the conservative therapy group.•The dichotomized global patient assessment showed statistically significant differences among treatment groups, with a higher rate of satisfaction in the TCA and sham acupuncture groups at week 26.•The SF-12 physical subscale at week 26 was also greater with TCA and sham acupuncture than with conservative therapy.   10/12 (High)
  2006, Germany\                        Inclusion criteria:(1)signed informed consent(2)age ≧40 years,(3)diagnosed by ACR criteria(4)chronic pain more than 6 months(5)K-L grade 2 or 3(6)a chronic pain score of at least 1, according to the criteria of von Korff and colleagues                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
  (RCT)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
  (Patient-blind in TCA and sham)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  Williamson L et al[@bib27]\           N = 181 (on the surgical list)\                                                                                                                                                                                                               Acupuncture group (N = 60):(1)acupoints were used in previous reported research,(2)"De-Qi",(3)left in-situ 20 min.Physiotherapy group (N = 60):(1)exercise circuit supervised by the same physiotherapist,(2)once a week, for 6 weeks.Standard management group (N = 61):(1)exercise and advice by consensus.                                                                                                                                                               •Pain: VAS(10-cm)•Function:Oxford Knee Score (OKS); WOMAC; a 50-m timed walk•Others:Hospital Anxiety and Depression score (HAD)                                                                                                                                                     •The **acupuncture group had a lower OKS** than the other two groups at 7 weeks.•During the 50-m timed walk, the physiotherapy group had a lowest mean walking time but no significant difference.•No significant pre-operative changes in HAD and WOMAC between the groups.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             10/12 (High)
  2007, UK\                             Inclusion criteria:(1)on the surgical list for knee arthroplasty,(2)bilateral or unilateral knee pain more than 3 months                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
  (RCT)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
  (Patient-blind)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
  (Assessor-blind)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  Jubb RW et al[@bib28]\                N = 68\                                                                                                                                                                                                                                       Acupuncture group (N = 34):(1)distal and local acupoints,(2)EA to anterior part for 10 min and then posterior part 10 minSham group (N = 10):(1)needle did not be inserted into the skin                                                                                                                                                                                                                                                                                    •Pain: VAS•Function: WOMAC\*; EuroQol•Others: plasma ß-endorphin concentration                                                                                                                                                                                                      •The comparison between the acupuncture and the sham group showed a statistically significant improvement (pain score) in the acupuncture group (p = 0.035).•No significant difference between the groups for EuroQol and WOMAC stiffness or function either at the end of treatment at week five or at the final visit at week nine.•Plasma ß-endorphin levels did not vary significantly during the study.                                                                                                                                                                                                                                                                                                                                                                             8/12 (Moderate)
  2008, UK\                             Inclusion criteria:(1)Age \>18 year,(2)symptoms of OA of the knee over than 6 months,(3)inadequate response to conventional treatment,(4)not on a surgical list                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
  (RCT)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
  (Patient-blind)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  Itoh K et al[@bib29]\                 N = 30 (age \>60 years, diagnosed OA according to ACR\* criteria)\                                                                                                                                                                            Standard acupuncture (N = 10):(1)traditional acupoints for knee pain,(2)De-Qi"Trigger point acupuncture (N = 10):(1)Trigger points,(2)local twitch by stimulationSham group (N = 10):(1)non-penerating needle,(2)A simulation of needle insertion and extraction was performed.                                                                                                                                                                                             •Pain: VAS(100-mm)•Function: WOMAC                                                                                                                                                                                                                                                  •The VAS of the TrP group was the lowest of the three, and the difference was statistically significant when compared with SH group (p = 0.025), but no significant difference was detected between TrP and SA (p = 0.47).•The lowest WOMAC score was found in the TrP group, and a statistically significant difference was detected between TrP and SH groups (p = 0.031).•No significant difference was detected between SA and SH groups.                                                                                                                                                                                                                                                                                                                                            8/12 (Moderate)
  2008, Japan\                          Inclusion criteria:(1)pain over 6 months,(2)K-L grade ≧2(3)no neurological sign,(4)no acupuncture in the previous 6 months(5)Inadequate response to conventional treatment                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
  (RCT)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
  (Patient-blind)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
  (Assessor-blind)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  Lu TW et al[@bib30]\                  N = 20\                                                                                                                                                                                                                                       Experimental group (N = 10):(1)a 30 min EA\*,(2)5 acupoints,(3)"De-Qi"Sham group (N = 10):(1)sham EA (line connected to needle but no power),(2)needle into the skin at points from 1 cm left to the acupoints,(3)No "De-Qi"                                                                                                                                                                                                                                                •Pain: VAS(10-cm)\*•Function: Gait analysis (Vicon 512, Oxford Metrics, UK)                                                                                                                                                                                                         •The VAS scores were decreased significantly after acupuncture treatment in both groups (the mean change of experimental group was 2 times than that of sham group).•The experimental group showed a great contrast to the sham group, with significant improvements in the gait variables (hip and knee flexion, ankle plantarflexion were increased significantly and hip extensor, knee extensor and ankle plantarflexor moments were all increased significantly).                                                                                                                                                                                                                                                                                                                   9/12 (Moderate)
  2010, Taiwan\                         Inclusion criteria:(1)bilateral medial compartment knee OA,(2)grade 2 or 3 of K-L^∗^,(3)ability to walk without assistance                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
  (RCT)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
  (Patient-blind)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              

  Soni A et al[@bib31]\                 N = 56\                                                                                                                                                                                                                                       Acupuncture and exercise therapy (N = 28):(1)Acupoints according to previous study,(2)exercise according to the procedures of standard exercise and advice leaflet.Standard exercise and advice leaflet (N = 28):(1)designed by consensus between the physiotherapy, rheumatology and orthopaedic departments.                                                                                                                                                              •Pain:VAS(10-cm)•Function:Oxford Knee Score (OKS);50 m timed walk•Others:the Hospital Anxiety and Depression score (HAD)                                                                                                                                                            •Combined acupuncture and physiotherapy is a pragmatic therapeutic option for patients with moderate to severe knee OA.•Patients in the treatment group were more likely to withdraw from the surgical waiting list due to sufficient symptomatic improvement although the effect was not statistically significant (OR 7.64, 95% CI 0.86 to 68.20).                                                                                                                                                                                                                                                                                                                                                                                                                                     8/12 (Moderate)
  2012, UK\                             Inclusion criteria:(1)Patients listed for knee arthroplasty due to OA who had unilateral or bilateral knee pain lasting more than 3 months.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
  (RCT)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
  (Parallel design)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  (Assessor-blind)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  Mavrommatis CI et al[@bib10]\         N = 120\                                                                                                                                                                                                                                      Acupuncture and etoricoxib (N = 40):(1)6 local and 4 distal acupoints,(2)"De-Qi",(3)EA in pairs ST36-SP9 and GB34-SP10Sham acupuncture and etoricoxib (N = 40):(1)the procedures were the same as real acupuncture but no needle insertion,(2)the same pairs of EA stimulationEtoricoxib only (N = 40):\                                                                                                                                                                    •Pain:WOMAC pain scale; VAS(100-mm); Pain Test; FDK 20 Algometer of Warner USA•Function:WOMAC stifness and function scale; Short Form-36 version 2•Others:BMI, CBC, ESR, Rh factor, liver and kidney function, uric acid and arterial blood pressure                                •WOMAC index score and its subscales at the end, week 8, are significant differences at all group.•Patients receiving acupuncture plus etoricoxib (group I) had significantly better results in all outcome measurements except for the WOMAC scales and the SF-36v2 mental component summary.•No significant differences in the laboratory test results between groups at the beginning and at the end of the treatment.•Follow-up (8--12 week), the superiority of response in the acupuncture plus pharmacological treatment group compared with responses in the other 2 groups remained statistically significant for all scales                                                                                                                                                    10/12 (High)
  2012, Greece\                         Inclusion criteria:(1)meet the ACR criteria(2)K-L grade ≧2(3)chronic pain more than 3 months                                                                                                                                                  All patients received 60 mg etoricoxib tablets once a day for 60 days.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
  (RCT)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
  (Patient-blind)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
  (Assessor-blind)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\*EA: electro-acupuncture.

\*VAS: visual analogue scale.

\*WOMAC: The Western Ontario and McMaster Universities Arthritis Index.

\*ACR: American College of Rheumatology.

\*K-L: Kellgren-Lawrence criteria.

###### 

Herbal patch for OA of the knee.

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author/Year\                        Participants                                                                                                                                                                            Intervention                                                                                                     Outcome assessment                                                   Results                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 The risk of bias
  Country/Design                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
  ----------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------
  Wang X et al[@bib13] 2012, China\   N = 150\                                                                                                                                                                                FNZG (N = 60)\                                                                                                   •Pain:VAS(100-mm)•Function:WOMAC•Others:TCM Syndrome Questionnaire   •All three groups improved with respect to a decrease from baseline to day 1 and day 7 in the VAS score, the greatest in FNZG and the smallest in SJG group at day 7.•Improvements from baseline to day 7 in the 3 WOMAC domains and total score were seen in three groups, the greatest in SJG without significant differences.•FNZG group had a significantly greater decrease in the item of fear of coldness as assessed by TCMSQ than that in placebo group but SJG group did not reach a significant reduction.   10/12 (High)
  (RCT)\                              Inclusion criteria:(1)Age between 40-70 years,(2)Diagnosed by the criteria of Chinese Orthopaedic Association and TCM syndrome(3)evidence of idiopathic OA,(4)Pain over 20/100 mm VAS   Extraction mainly from *Rhizoma Arisaematis, Radix Aconiti*, *Flos Caryophylli* and nine herbs.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
  (Patient-blind)\                                                                                                                                                                                                            SJG (N = 60)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
  (Assessor-blind)\                                                                                                                                                                                                           Extraction mainly from *Rhizoma Arisaematis, Radix Aconiti*, and fifteen herbs.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              
  (Care giver-Blind)                                                                                                                                                                                                          Placebo patch (N = 30)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
                                                                                                                                                                                                                              Acrylic pressure-sensitive adhesive tape\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     
                                                                                                                                                                                                                              All patches had the same size of 10 cm × 13 cm and were matched with each other for taste, color, and package.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Herbs for OA of the knee.

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author/Year\             Participants                                                                                                                                                           Intervention                                                                                                                                                                                                                                                                             Outcome assessment                                                                                                                                                                                                            Results                                                                                                                                                                                                                                                                                                                                                                           The risk of bias
  Country/Design                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  ------------------------ ---------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------
  Park SH et al[@bib32]\   N = 57\                                                                                                                                                                AIF group (N = 31)\                                                                                                                                                                                                                                                                      •Pain:VAS(100-mm)•Function:K-WOMAC                                                                                                                                                                                            •Decreases in VAS scores were significant in both study groups and the rate of response to AIF was 4.76 percentage points higher at 6 weeks than placebo group, however no significant difference was found between the two groups.•Assessments of K-WOMAC scores showed significant improvements in pain, stiffness, physical function and total scores in the AIF group only.   9/12 (Moderate)
  2009, Korea\             Inclusion criteria:\                                                                                                                                                   the formulation which contained 200 mg of AIF (Ginsenoside Rb1, stachyose and eleutheroside E), 192 mg of corn starch, 4 mg of HPMC, 4 mg of magnesium stearate in each capsule.\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
  (RCT)\                   (1)Age from 43 to 73 years, (2)Diagnosis according to ACR criteria, (3)K-L grade 1--2, (4)stop all analgesic medication and physical therapy for 1 week before study   Placebo group (N = 26) the formulation of 392 mg of corn starch, 4 mg of HPMC, 4 mg of magnesium stearate in each capsule.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
  (Patient-blind)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         
  (Care giver-blind)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       

  Li XH et al[@bib33]\     N = 100\                                                                                                                                                               **Treatment group** (N = 50)(1)Chinese medicine for resolving phlegm and removing damp,(2)orally taken twice a day, for 2 courses of treatment.**Control group** (N = 50)(1)Votalin tablet 25 mg each time and Vitamin C 20 mg each time,(2)3 times a day, for 2 courses of treatment.   •Pain (0--3)•Morning stiffness (0--3)•Walking (0--3)•Stand up from sitting position (0--3)•Walk unrestrictedly (0--3)•Lassitude in the loin and knees (0--3)•Daily activity (0--3)•Carry out all kinds of activities (0--3)   •The total score for symptoms obviously declined after treatment in both groups.•The decreased symptoms and effective rate were better in the treatment group but no statistic difference.•X-ray manifestation on patients before and after treatment in the two groups was basically identical without obvious change.                                                           5/12 (Low)
  2010, China\             Inclusion criteria:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
  (RCT)                    (1) diagnosis according to ACR criteria, (2) diagnosis in TCM according to Directing Principle for Clinical Research of New Chinese Drugs, (3) X-ray grading                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Qigong for OA of the knee.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author/Year\             Participants                                                                                                                                                                                                   Intervention                                                                                                                                                                                                                                                          Outcome assessment                                                                                                                                                                                                                                                                                Results                                                                                                                                                                                                                                                                                                                                                                                                                                                                          The risk of bias
  Country/Design                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   
  ------------------------ -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------
  Chen KW et al[@bib14]\   N = 112\                                                                                                                                                                                                       EQT group (N = 60):(1)Two qigong therapists were invited to perform EQT in this study.(2)There is no standard procedure for EQT in the field.Control group (N = 52):(1)a sham healer to mimic EQT.                                                                    •Pain:McGill Pain Questionnaire (MPQ-SF)•Function:WOMAC; Time to walk a 15-m straight path; ROM when squatting down to the lowest position without pain•Others:the Spielberger State Trait; Anxiety Scale; the Center for Epidemiologic Studies Depression Scale; an adopted general mood index   •There are significant differences between healer 2 and the placebo group in reduced pain measured by MPQ (p \< 0.05) and slightly reduced time for walking 15 m (p = 0.08) after treatment.•Differences in pain reduction are smaller between healer 1 and the placebo group (p = 0.09) and are not statistically significant for reduced time in walking 15 m (p = 0.35).•For psychological outcomes, no significant differences were found in depression or anxiety scales.   10/12 (High)
  2008, USA\               Inclusion criteria:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
  (RCT)\                   (1)diagnosis according to ACR criteria at least 6 months prior to evaluation, (2)physical examination before the study to confirm the diagnosis, (3) agreed to maintain a stable analgesic dose during study                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
  (Patient-blind)\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
  (Assessor-blind)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  An B et al[@bib34]\      N = 28 (diagnosis according to ACR criteria)\                                                                                                                                                                  Baduanjin intervention (N = 14):(1)eight sections, and each section needs to be repeated 20 times.Control group (N = 14):(1)No intervention was undertaken for the control group.                                                                                     •Pain:WOMAC pain scale•Function:WOMAC; SF-36; 6-MWT; ISKE                                                                                                                                                                                                                                         •Compared with the control group, the participants in the Baduanjin group had statistically significant improvements in percentage changes of the WOMAC pain subscale, the WOMAC stiffness subscale, 0.029), the WOMAC physical function subscale, 6-MWT, and Peak Torque of the ISKE.•The SF-36\'s General Health, Social Function, and Mental Health subscales had no significant changes between those in the Baduanjin and control groups.                                   5/12 (Low)
  2008, China\             Inclusion criteria:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
  (RCT)                    (1)symptoms at least 6 months before study, (2) no current exercise programe, (3) willingness to participate in the study                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               

  Lee HJ et al[@bib35]\    N = 41\                                                                                                                                                                                                        T\'ai chi (太極拳 tài jí quán) (N = 28):(1)1 h, and repeated twice a week for eight weeks,(2)18 movements,(3)focus on releasing tension in the physical body and mind acting in concert with breathing.Control (N = 13):(1)no intervention during the study period.   •Pain: No pain score.•Function:WOMAC; The 6-m walking test•Others:Short Form 36 (SF-36); Health Survey                                                                                                                                                                                            •The T\'ai chi group showed significant improvements in the total SF-36 score compared with the control group.•The T\'ai chi group showed improvements in total WOMAC score compared with the control group.•In the 6-m walking test, the T\'ai chi group spent significantly shorter times.                                                                                                                                                                                     10/12 (High)
  2009, Korea\             Inclusion criteria:\                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
  (RCT)\                   (1)K-L grade≧2 at least 6 months, (2) no current exercise programme, (3)age from 50 to 80 years.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
  (Assessor-blind)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

###### 

Methodological quality assessment and risk-of-bias (Acupuncture (針灸 zhēn jiǔ)).

                              Adequate randomization   Concealed allocation   Groups similar at baseline   Patient blinded   Care provider blinded   Outcome assessor blinded   Dropout rate described and acceptable   Intention to treat analysis   Co-interventions avoided or similar   Compliance acceptable   Timing outcome assessment similar   Report free of selective outcome reporting   Total
  --------------------------- ------------------------ ---------------------- ---------------------------- ----------------- ----------------------- -------------------------- --------------------------------------- ----------------------------- ------------------------------------- ----------------------- ----------------------------------- -------------------------------------------- -------
  Ng MM et al 2003            Yes                      Unclear                Yes                          Yes               No                      Yes                        Yes                                     Yes                           Yes                                   Yes                     Yes                                 Yes                                          10/12
  Berman BM et al 2004        Yes                      Yes                    Yes                          Yes               No                      Yes                        Yes                                     Yes                           Yes                                   Yes                     Yes                                 Yes                                          11/12
  Tukmachi E et al 2004       Yes                      Yes                    No                           No                No                      No                         Yes                                     Yes                           No                                    Yes                     Yes                                 Yes                                          7/12
  Vas J et al 2004            Yes                      Yes                    Yes                          Yes               No                      Yes                        Yes                                     Yes                           Yes                                   No                      Yes                                 Yes                                          10/12
  Witt C et al 2005           Yes                      Unclear                Yes                          Yes               No                      Yes                        Yes                                     Yes                           Yes                                   Yes                     Yes                                 Yes                                          10/12
  Scharf HP et al 2006        Yes                      Yes                    Yes                          Yes               No                      Yes                        Yes                                     Yes                           No                                    Yes                     Yes                                 Yes                                          10/12
  Williamson L et al 2007     Yes                      Yes                    Yes                          Yes               No                      Yes                        Yes                                     Yes                           Yes                                   Yes                     Yes                                 No                                           10/12
  Jubb RW et al 2008          Unclear                  Unclear                Yes                          Yes               No                      Yes                        Yes                                     No                            Yes                                   Yes                     Yes                                 Yes                                          8/12
  Itoh K et al 2008           Unclear                  Unclear                Yes                          Yes               No                      Yes                        Yes                                     Unclear                       Yes                                   Yes                     Yes                                 Yes                                          8/12
  Lu TW et al 2010            Unclear                  Yes                    Yes                          Yes               No                      No                         Yes                                     Yes                           Yes                                   Yes                     Yes                                 Yes                                          9/12
  Soni A et al 2012           Yes                      Yes                    No                           No                No                      Yes                        No                                      Yes                           Yes                                   Yes                     Yes                                 Yes                                          8/12
  Mavrommatis CI et al 2012   Yes                      Yes                    Yes                          Yes               No                      Yes                        Yes                                     Unclear                       Yes                                   Yes                     Yes                                 Yes                                          10/12

###### 

Methodological quality assessment and risk-of-bias (Herbal patch).

                      Adequate randomization   Concealed allocation   Groups similar at baseline   Patient blinded   Care provider blinded   Outcome assessor blinded   Dropout rate described and acceptable   Intention to treat analysis   Co-interventions avoided or similar   Compliance acceptable   Timing outcome assessment similar   Report free of selective outcome report in   Total
  ------------------- ------------------------ ---------------------- ---------------------------- ----------------- ----------------------- -------------------------- --------------------------------------- ----------------------------- ------------------------------------- ----------------------- ----------------------------------- -------------------------------------------- -------
  Wang X et al 2012   Unclear                  Unclear                Yes                          Yes               Yes                     Yes                        Yes                                     Yes                           Yes                                   Yes                     Yes                                 Yes                                          10/12

###### 

Methodological quality assessment and risk-of-bias (Herbal medicine).

                       Adequate randomization   Concealed allocation   Groups similar at baseline   Patient blinded   Care provider blinded   Outcome assessor blinded   Dropout rate described and acceptable   Intention to treat analysis   Co-interventions avoided or similar   Compliance acceptable   Timing outcome assessment similar   Report free of selective outcome reporting   Total
  -------------------- ------------------------ ---------------------- ---------------------------- ----------------- ----------------------- -------------------------- --------------------------------------- ----------------------------- ------------------------------------- ----------------------- ----------------------------------- -------------------------------------------- -------
  Park SH et al 2009   Unclear                  Unclear                Yes                          Yes               Yes                     Unclear                    Yes                                     Yes                           Yes                                   Yes                     Yes                                 Yes                                          9/12
  Li XH et al 2010     Unclear                  Unclear                Yes                          Unclear           Unclear                 Unclear                    Yes                                     Yes                           Unclear                               Yes                     Unclear                             Yes                                          5/12

###### 

Methodological quality assessment and risk-of-bias (Qigong (氣功 qì gōng)).

                       Adequate randomization   Concealed allocation   Groups similar at baseline   Patient blinded   Care provider blinded   Outcome assessor blinded   Dropout rate described and acceptable   Intention to treat analysis   Co-interventions avoided or similar   Compliance acceptable   Timing outcome assessment similar   Report free of selective outcome reporting   Total
  -------------------- ------------------------ ---------------------- ---------------------------- ----------------- ----------------------- -------------------------- --------------------------------------- ----------------------------- ------------------------------------- ----------------------- ----------------------------------- -------------------------------------------- -------
  Chen KW et al 2008   Yes                      Yes                    Yes                          Yes               No                      Yes                        Yes                                     No                            Yes                                   Yes                     Yes                                 Yes                                          10/12
  An B et al 2008      Unclear                  Unclear                Yes                          No                No                      Unclear                    No                                      No                            Yes                                   Yes                     Yes                                 Yes                                          5/12
  Lee HJ et al 2009    Yes                      Yes                    Yes                          No                No                      Yes                        Yes                                     Yes                           Yes                                   Yes                     Yes                                 Yes                                          10/12

###### 

Acupuncture (針灸 zhēn jiǔ) for osteoarthritis of the knee (膝關節炎 xī guān jié yán) (GRADE).

  Number of studies          Design   Limitation                                              Inconsistency                                                 Indirectness                                                 Imprecision              Publication bias   Other considerations   Quality
  -------------------------- -------- ------------------------------------------------------- ------------------------------------------------------------- ------------------------------------------------------------ ------------------------ ------------------ ---------------------- ----------
  Pain after treatment                                                                                                                                                                                                                                                                      
  12                         RCT      Serious limitation[a](#tbl11fna){ref-type="table-fn"}   No serious inconsistency[b](#tbl11fnb){ref-type="table-fn"}   No serious indirectness[c](#tbl11fnc){ref-type="table-fn"}   No serious imprecision   Undetected         None                   Moderate
  Function after treatment                                                                                                                                                                                                                                                                  
  12                         RCT      Serious limitation[a](#tbl11fna){ref-type="table-fn"}   Serious[d](#tbl11fnd){ref-type="table-fn"}                    No serious indirectness[e](#tbl11fne){ref-type="table-fn"}   No serious imprecision   Undetected         None                   Low

Three studies were unclear random sequence generation. Four were unclear allocation concealment. Two were inadequate Selection of participants to groups. Three were no intention-to-treat principle. Three were inadequate blinding. Only two studies did not have serious limitations.

Nine studies were consistent with acupuncture to relief pain after treatment and had significant differences. One study achieved pain release without significant differences. The results of two studies without serious limitations were no significant differences about pain release.

Five studies had similar populations (age, diagnosis and severity) but patients of twelve studies were all diagnosed osteoarthritis. Eight studies used VAS for estimate the pain of the knee and four used other method to evaluate the severity of the pain.

Seven studies were consistent with acupuncture to improve function and had significant differences. The others did not achieve improved function. One study without serious limitations had improved function with significant differences.

Five studies had similar populations (age, diagnosis and severity) and patients of twelve studies were all diagnosed osteoarthritis. Nine studies used WOMAC as their outcome measurement of the function of the knee.

###### 

Herbs for osteoarthritis of the knee (膝關節炎 xī guān jié yán) (GRADE).

  Number of studies          Design   Limitation                                              Inconsistency                                              Indirectness                                              Imprecision                                              Publication bias   Other considerations   Quality
  -------------------------- -------- ------------------------------------------------------- ---------------------------------------------------------- --------------------------------------------------------- -------------------------------------------------------- ------------------ ---------------------- ---------
  Pain after treatment                                                                                                                                                                                                                                                                                                
  2                          RCT      Serious limitation[a](#tbl12fna){ref-type="table-fn"}   Serious inconsistency[b](#tbl12fnb){ref-type="table-fn"}   Serious indirectness[c](#tbl12fnc){ref-type="table-fn"}   Serious imprecision[c](#tbl12fnc){ref-type="table-fn"}   Undetected         None                   --
  Function after treatment                                                                                                                                                                                                                                                                                            
  2                          RCT      Serious limitation[a](#tbl12fna){ref-type="table-fn"}   Serious inconsistency[d](#tbl12fnd){ref-type="table-fn"}   Serious indirectness[c](#tbl12fnc){ref-type="table-fn"}   Serious imprecision[c](#tbl12fnc){ref-type="table-fn"}   Undetected         None                   --

Two studies had both unclear random sequence generation and allocation concealment.

Two studies both had decreased pain after treatment but no significant differences.

One study had no reliability and validity of the outcome measurement.

One study had improved function with statistic difference but the other without statistic difference.

###### 

Qigong (氣功 qì gōng) for osteoarthritis of the knee (膝關節炎 xī guān jié yán) (GRADE).

  Number of studies          Design   Limitation                                              Inconsistency                                                 Indirectness                                              Imprecision                                              Publication bias   Other considerations   Quality
  -------------------------- -------- ------------------------------------------------------- ------------------------------------------------------------- --------------------------------------------------------- -------------------------------------------------------- ------------------ ---------------------- ----------
  Pain after treatment                                                                                                                                                                                                                                                                                                   
  3                          RCT      Serious limitation[a](#tbl13fna){ref-type="table-fn"}   Serious inconsistency[b](#tbl13fnb){ref-type="table-fn"}      Serious indirectness[b](#tbl13fnb){ref-type="table-fn"}   Serious imprecision[b](#tbl13fnb){ref-type="table-fn"}   Undetected         None                   --
  Function after treatment                                                                                                                                                                                                                                                                                               
  3                          RCT      Serious limitation[a](#tbl13fna){ref-type="table-fn"}   No serious inconsistency[c](#tbl13fnc){ref-type="table-fn"}   No serious indirectness                                   No serious imprecision                                   Undetected         None                   Moderate

One study had both unclear random sequence generation and allocation concealment. Two studies had no intention-to-treat analysis.

One study did not have pain score but had the WOMAC index that has a subscale of the pain scale. Two studies had decreased pain scale with significant differences.

Two studies had improved function without significant differences and one with significant differences.
